Search clinical trials for: Angiotensin II

Total 8561 results

Shiga University

Unknown

Rationale and Design for Shiga Microalbuminuria Reduction Trial

Hypertension | Diabetes Mellitus | Albuminuria

Japan
Universidade do Porto
Rede de Investigação em Saúde (RISE), Laboratório Associado; Faculty of Medicine... and other collaborators

Recruiting

Initiation of ARNi and SGLT2i in Patients With HFrEF (INITIATE)

Heart Failure With Reduced Ejection Fraction

Portugal
Organon and Co

Completed

A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

Hypertension | Metabolic Disorder
Organon and Co

Completed

Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)

Hypertension
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Cardiovascular Disease and Obstructive Sleep Apnea (CVD/OSA)

Hypertension | Severe Obstructive Sleep Apnea (Apnea Hypopnea Index > 30 Events/Hour)

United States
Italian Society of Cardiology
Federico II University; University Of Perugia; University of Messina; Azienda Ospedaliero-Universitaria... and other collaborators

Completed

Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction

Left Ventricular Dysfunction | Ventricular Remodeling | Heart Failure, Left Sided

Italy
LG Chem

Unknown

To Evaluate Safety and Effectiveness of RovatitanTab.

Hypertension | Hyperlipidemias
Boehringer Ingelheim

Completed

Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan

Non-alcoholic Fatty Liver Disease

Japan
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions

Hypertension

United States
Kurume University

Unknown

Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension

Japan
HanAll BioPharma Co., Ltd.

Completed

Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia

Essential Hypertension | Hyperlipidemia

Korea, Republic of
Chinese PLA General Hospital
Tianjin TongRenTang Group Co., Ltd.

Unknown

Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

Proteinuria | Glomerulonephritis

China
Boehringer Ingelheim

Completed

Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects

Healthy
Boehringer Ingelheim

Completed

Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

Hypertension
Novartis Pharmaceuticals

Completed

Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day

Hypertension

France, Tunisia
Merck Sharp & Dohme LLC

Completed

Antihypertensive Response to Losartan and Genetic Polymorphisms

Hypertension
Sanofi
Bristol-Myers Squibb

Completed

AMISH : Aprovel for Management of Isolated Systolic Hypertension

Hypertension

Korea, Republic of, Mexico, Taiwan, Thailand, Philippines, Chile, China, Indonesia
Shanghai Chest Hospital

Not yet recruiting

Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients

Cardiac Event | Immune Checkpoint Inhibitor | Adverse Reactions | Non-Small Cell Lung Cancer Patients
Austin Health
Northern Health and Social Care Trust; Western Hospital, Australia

Unknown

Angiotensin in Septic Kidney Injury Trial (ASK-IT)

Sepsis | Septic Shock | Acute Renal Failure

Australia
Viatris Inc.

Not yet recruiting

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

Bioequivalence Study

Thailand
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis (PRECISION-BP)

Cardiovascular Diseases | Hypertension | Obesity | Nocturnal Blood Pressure | Natriuretic Peptides | Renin-Angiotensin-Aldosterone System

United States
University of Pennsylvania

Suspended

Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

Hypertension | Diabetes Mellitus, Type 2 | Pre-diabetic | Elevated Blood Pressure

United States
Fan Fan Hou

Completed

The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients (MAIN)

IgA Nephropathy

China
Amsterdam UMC, location VUmc

Completed

Renohemodynamic Effects of Combined empagliflOzin and LosARtan (RECOLAR)

Diabetes Mellitus, Type 2 | Diabetic Kidney Disease

Netherlands
University of Texas Southwestern Medical Center
Novartis Pharmaceuticals

Withdrawn

Regression of Fatty Heart by Valsartan Therapy

Metabolic Syndrome | Lipotoxicity

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.

Healthy
Vanderbilt University

Terminated

Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression

Depression | Hypertension

United States
Boehringer Ingelheim

Completed

Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers

Healthy
Bayer

Completed

Xirtam H Combination In the Treatment of Hypertension Evaluation Study. (XCITE)

Hypertension

India
Radboud University Medical Center

Completed

Nijmegen Antihypertensive Management Improvement Study (NAMIS)

Primary Hypertension

Netherlands
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

Hypertension

United States, Chile, Russian Federation, Mexico, Peru
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

Healthy

United States
AstraZeneca

Completed

Candesartan Effect in Second Stage Arterial Hypertension (CAESAR)

Stage II Hypertension

Korea, Republic of
Università degli Studi dell'Insubria

Unknown

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine

HIV Infections | Hypertension

Italy
Daiichi Sankyo, Inc.

Completed

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

Hypertension

United States
Novartis Pharmaceuticals

Completed

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI (PARADISE-MI)

Acute Myocardial Infarction

China, United States, South Africa, Italy, Spain, Croatia, Czechia, Hungary, Romania, Taiwan, Belgium, Germany, Netherlands, Austria, Denmark, United Kingdom, Thailand, Argentina, Israel, Australia, Bulgaria, France, Greece, Russian Federation and more
Soroka University Medical Center

Completed

Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy

Radiographic Contrast Agent Nephropathy
International Bio service

Not yet recruiting

Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

Healthy Volunteer
University of Florida
National Institute on Aging (NIA); Abbott

Completed

The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study (ENRGISE)

Inflammation

United States
University of Sydney
The George Institute for Global Health, India

Terminated

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19 (CLARITY 2)

COVID-19 | SARS-CoV2 Infection

India
Ohio State University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

Obesity | PreDiabetes | Blood Pressure | Impaired Glucose Tolerance

United States
Eli Lilly and Company

Completed

A Study of LY900020 in Healthy Chinese Participants

Healthy

Singapore
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Hypertension

Switzerland, Germany
Novartis

Completed

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Hypertension

Switzerland, Germany
Aristotle University Of Thessaloniki

Withdrawn

Irbesartan Versus Amlodipine: The OBI Study (OBI)

Hypertension | Obesity

Greece
Boehringer Ingelheim

Completed

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Hypertension

Japan
Severance Hospital

Completed

Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers

Healthy

Korea, Republic of
Novartis

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

Hypertension

United States
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension

Hypertension

United States, Canada, Germany, Russian Federation, France
Pfizer

Terminated

A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

Hypertension

Taiwan

Search clinical trials for: Angiotensin II

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations